<DOC>
	<DOCNO>NCT01426958</DOCNO>
	<brief_summary>To study effect P-glycoprotein inhibitor ritonavir pharmacokinetics ( PK ) afatinib depend timepoint ritonavir administration</brief_summary>
	<brief_title>Investigation Ritonavir Effects Afatinib Exposure Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<criteria>Inclusion criterion : 1. healthy male subject Exclusion criterion : 1. relevant deviation healthy condition</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>